October 30
11 - 50
Director of Drug Product Manufacturing for oncology and autoimmune biopharmaceuticals.
πΊπΈ United States β Remote
π° $10M Post-IPO Equity on 2022-03
β° Full Time
π΄ Lead
π Director
October 19
11 - 50
Clinical Research Scientist for oncology product development at Cullinan Therapeutics.
πΊπΈ United States β Remote
π° $10M Post-IPO Equity on 2022-03
β° Full Time
π Senior
π§ͺ Clinical Research
October 4
11 - 50
Quality Assurance Manager at a biopharmaceutical company ensuring compliance and quality standards.
πΊπΈ United States β Remote
π° $10M Post-IPO Equity on 2022-03
β° Full Time
π Senior
π§ QA Engineer (Quality Assurance)
September 27
11 - 50
Pharmacovigilance Scientist at Cullinan Therapeutics developing safety strategies for products.
πΊπΈ United States β Remote
π° $10M Post-IPO Equity on 2022-03
β° Full Time
π Senior
π Director
July 16
11 - 50
Develop and implement global regulatory strategies for clinical assets in biopharmaceutical company
πΊπΈ United States β Remote
π° $10M Post-IPO Equity on 2022-03
β° Full Time
π Senior
π Compliance